SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Emami spurts on subsidiary acquiring controlling stake of 66.67% in Fravin Australia

22 Jan 2015 Evaluate

Emami is currently trading at Rs. 888.20, up by 29.75 points or 3.47 % from its previous closing of Rs. 858.45 on the BSE.

The scrip opened at Rs. 860.70 and has touched a high and low of Rs. 930.05 and Rs. 860.70 respectively. So far 80484 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 895.00 on 14-Jan-2015 and a 52 week low of Rs. 421.00 on 28-Jan-2014.

Last one week high and low of the scrip stood at Rs. 894.00 and Rs. 847.00 respectively. The current market cap of the company is Rs. 20495.18 crore.

The promoters holding in the company stood at 72.74 % while Institutions and Non-Institutions held 17.99 % and 9.28 % respectively.

Emami’s UAE- based wholly owned subsidiary Emami Overseas FZE has acquired controlling stake of 66.67% in Fravin Pty (Fravin), a company based in Australia with major strength in R&D and manufacture of natural and organic personal care products in Australia. Consequent to the above acquisition, Fravin along-with its three subsidiary companies has also become subsidiaries of Emami.

Emami manufactures products under various categories namely Hair Care, Skin Creams and Lotions, Talcum Powder and ayurvedic health care products. Emami's Boroplus portfolio is worth Rs 400 crore, comprising of three brands -- BoroPlus Antiseptic Cream, Boroplus Advanced Moisturizing Lotion and BoroPlus Prickly Heat Powder.

Emami Share Price

451.45 25.50 (5.99%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Hindustan Unilever 2241.10
Godrej Consumer Prod 1108.20
Dabur India 442.10
Colgate Palmol. (I) 2106.20
P&G Hygiene 10006.55
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×